AIFF
AIFF
NASDAQ · Health Care

Firefly Neuroscience Inc

$1.69
-0.32 (-15.92%)
As of Sep 28, 10:41 PM ET ·
Financial Highlights (FY 2026)
Revenue
1.06M
Net Income
-18,415,607
Gross Margin
56.5%
Profit Margin
-1,741.0%
Rev Growth
-54.4%
D/E Ratio
—
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 56.5% 56.5% 60.8% 60.8%
Operating Margin -894.0% -804.6% 16.3% 14.6%
Profit Margin -1,741.0% -1,653.9% 13.5% 12.5%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 1.06M 2.32M 3.88M 4.00M
Gross Profit 597.6K 1.31M 2.36M 2.43M
Operating Income -9,458,543 -18,655,903 632.7K 584.7K
Net Income -18,415,607 -36,322,696 521.8K 498.1K
Gross Margin 56.5% 56.5% 60.8% 60.8%
Operating Margin -894.0% -804.6% 16.3% 14.6%
Profit Margin -1,741.0% -1,653.9% 13.5% 12.5%
Rev Growth -54.4% -54.4% -0.8% -2.1%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 2.46M 2.16M
Total Equity — — 7.46M 6.84M
D/E Ratio — — 0.33 0.32
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -9,296,550 -19,355,078 825.5K 921.5K
Free Cash Flow — — 314.5K 247.7K